Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients

NCT00503516 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

39

Enrollment

INDUSTRY

Sponsor class

Stopped Difficulties to recruit the patients following the inclusion criteria

Conditions

Dementia

Interventions

DRUG: Megestrol acetate
DRUG: Placebo

Sponsor

Rottapharm Spain